Insulin prices averaged 19 cents per unit as of the quarter started Oct. 2024, marking the lowest level recorded in a decade, according to research from GoodRx, based on sources such as ...

Pet owners now have a new online resource that can help them save money. GoodRx, a company known for offering consumers coupons and discounts on prescription drugs, has a new arm of its company ...

In a disclaimer, GoodRx noted that the list was created by prioritizing "first-in-class medications and vaccines that are expected to have a significant impact on human health." "This was defined ...

GoodRx is monitoring seven potential FDA drug approvals in 2025, including a possible expanded label for Ozempic. Here are this year's most anticipated approval decisions, according to a GoodRx ...

Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...

The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential new use, to reduce the risk of renal failure and cardiovascular death in people with chronic ...

The SGLT2 inhibitor empagliflozin did not lower the risk of a first hospitalization for heart failure (HF) or death from any cause among patients with an increased risk for HF following acute ...

Patients with acute myocardial infarction are at a high risk of heart failure and death. Despite advances in care and reduction in the rate of recurrent myocardial infarctions, the risk for heart ...